insights_auto
Pse është rritur MVIR 2,33%?
Zhytu më thellëchevron_right
MVIR:STO
Medivir AB
1,49 SEK
arrow_upward
+2,33%(+0,034) 1D
9 tet, 5:29:42 m.d., GMT+2 · SEK
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për MVIR...
Hap
1,47 SEK
I lartë
1,50 SEK
I ulët
1,45 SEK
Kapitalizimi i tregut
932,52 mln
Vëllimi mesatar
1,41 mln
Vëllimi
1,73 mln
Maksimumi 52-javor
2,88 SEK
Minimumi 52-javor
0,34 SEK
Fitimet për aksion
-0,37 SEK
Aksionet në qarkullim
624,18 mln
Numri i punonjësve
6
Hap
1,47 SEK
I lartë
1,50 SEK
I ulët
1,45 SEK
Kapitalizimi i tregut
932,52 mln
Vëllimi mesatar
1,41 mln
Vëllimi
1,73 mln
Maksimumi 52-javor
2,88 SEK
Minimumi 52-javor
0,34 SEK
Fitimet për aksion
-0,37 SEK
Aksionet në qarkullim
624,18 mln
Numri i punonjësve
6
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Simply Wall Street
·
16 minuta më parë
Will Reseller Deal Change Five9 (FIVN) Narrative
MarketBeat
·
39 minuta më parë
BRP (NASDAQ:DOO) Stock Gets Downgrade from Zacks Research
GuruFocus
·
54 minuta më parë
Weekend Morning Brew: S&P 500 Hits Record Highs Amid Tech Rally
Detroit Free Press
·
1 orë më parë
How an S&P 500 high, then some reality checks hit markets this week
Profili
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Rreth Medivir AB